Keyword Search
Legend:
CC = Baltimore Convention Center, H = Hilton Baltimore
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: benefit-risk returned 6 record(s)
|
|
Wednesday, 08/02/2017
|
On a Stepwise Quantitative Approach for Benefit-Risk Assessment
Weili He, Merck & Co., Inc.; Yaxuan Sun, Department of Statistics, Iowa State University, Ames, IA, USA; Qing Li, Merck & Co., Inc.; Sabrina Wan, Merck & Co., Inc.
2:05 PM
|
Using Patient Preference Information in Benefit-Risk Assessment
Xuefeng Li, FDA; George Quartey , Genetech
2:45 PM
|
Rationale for the Use of Subject Level Information for Benefit-Risk Evaluations
Shihua Wen, Novartis; Weili He, Merck & Co., Inc.; Scott Evans, Harvard University ; Qi Jiang, Amgen Inc.; Jonathan Norton, Takeda; Xuefeng Li, FDA; George Quartey , Genetech
3:05 PM
|
|
|
